GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Cyanotech Corp (OTCPK:CYAN) » Definitions » Sloan Ratio %

Cyanotech (Cyanotech) Sloan Ratio % : -14.91% (As of Dec. 2023)


View and export this data going back to 1993. Start your Free Trial

What is Cyanotech Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Cyanotech's Sloan Ratio for the quarter that ended in Dec. 2023 was -14.91%.

As of Dec. 2023, Cyanotech has a Sloan Ratio of -14.91%, indicating there is a warning stage of accrual build up.


Cyanotech Sloan Ratio % Historical Data

The historical data trend for Cyanotech's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyanotech Sloan Ratio % Chart

Cyanotech Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Sloan Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.49 -1.99 -2.33 3.26 -0.91

Cyanotech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.90 -0.91 -7.20 -14.70 -14.91

Competitive Comparison of Cyanotech's Sloan Ratio %

For the Packaged Foods subindustry, Cyanotech's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cyanotech's Sloan Ratio % Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Cyanotech's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Cyanotech's Sloan Ratio % falls into.



Cyanotech Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Cyanotech's Sloan Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Sloan Ratio=(Net Income (A: Mar. 2023 )-Cash Flow from Operations (A: Mar. 2023 )
-Cash Flow from Investing (A: Mar. 2023 ))/Total Assets (A: Mar. 2023 )
=(-3.44--2.1
--1.068)/29.728
=-0.91%

Cyanotech's Sloan Ratio for the quarter that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Dec. 2023 )
=(-4.616--0.179
--0.373)/27.254
=-14.91%

Cyanotech's Net Income for the trailing twelve months (TTM) ended in Dec. 2023 was -1.43 (Mar. 2023 ) + -1.369 (Jun. 2023 ) + -0.797 (Sep. 2023 ) + -1.02 (Dec. 2023 ) = $-4.62 Mil.
Cyanotech's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2023 was 0.583 (Mar. 2023 ) + -0.596 (Jun. 2023 ) + 0.834 (Sep. 2023 ) + -1 (Dec. 2023 ) = $-0.18 Mil.
Cyanotech's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2023 was -0.05 (Mar. 2023 ) + -0.15 (Jun. 2023 ) + -0.136 (Sep. 2023 ) + -0.037 (Dec. 2023 ) = $-0.37 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cyanotech  (OTCPK:CYAN) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Dec. 2023, Cyanotech has a Sloan Ratio of -14.91%, indicating there is a warning stage of accrual build up.


Cyanotech Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Cyanotech's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cyanotech (Cyanotech) Business Description

Traded in Other Exchanges
N/A
Address
73-4460 Queen Kaahumanu Highway, Suite 102, Kailua-Kona, HI, USA, 96740
Cyanotech Corp is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The company's products include BioAstin Hawaiian Astaxanthin and Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. BioAstin Hawaiian Astaxanthin is a dietary antioxidant shown to support and maintain the body's natural inflammatory response, enhance skin, and support eye and joint health. It derives maximum revenue from the Packaged product and geographically from the United States.
Executives
Kakuk Collette Nicole officer: Chief Strategic Comml Officer 73-4460 QUEEN KAAHUMANU HWY SUITE 102, KAILUA-KONA HI 96740
Michael A / Davis director, 10 percent owner 1621 JUANITA LANE, TIBURON CA 94920
Angela May Mcelwee director 73-4460 QUEEN KAAHUMANU HWY SUITE 102, KAILUA-KONA HI 96740
Charles Jason Hartmann officer: VP, Sales & Marketing 73-4460 QUEEN KAAHUMANU HWY SUITE 102, KAILUA-KONA HI 96740
Glenn Jensen officer: VP-Operations 73-4460 QUEEN KAAHUMANU HWY #102, KAILUA-KONA HI 96740
Jennifer M. Johansen officer: VP of Quality 73-4460 QUEEN KAAHUMANU HWY #102, KAILUA KONA HI 96740
Walter Bennett Menzel director 45 MOUNT TIBURON ROAD, TIBURON CA 94920
Felicia I Ladin officer: CFO, VP Fin & Admin, Treasurer 26 CORPORATE CIRCLE, ALBANY NY 12203
Matthew Keith Custer officer: Vice President, Gen Mgr 73-4460 QUEEN KAAHUMANU HWY #102, KAILUA KONA HI 96740
Amy Beth Nordin officer: VP, HR, Secretary 73-4460 QUEEN KAAHUMANU HWY. SUITE 102, KAILUA-KONA HI 96740
Brian Brett Orlopp officer: CFO, VP, Treasurer, Secretary 73-4460 QUEEN KAAHUMANU HWY #102, KAILUA KONA CA 96740
Gerald J Watts officer: COO 2530 RED HILL AVE, SANTA ANA CA 92705
Mawae Morton officer: President 7473 MAKA'A STREET, HONOLULU HI 96825
Nancy E Katz director CALYPTE BIOMEDICAL CORP, 1265 HARBOR BAY PKWY, ALAHEDA CA 94502
David M Mulder director 21771 CALATRAVA, MISSION VIEJO CA 92692